Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran

European Journal of Neurology

Volumn 14, Issue 4, 2007, Pages 403-407

  Maghzi, A H ^a,b   Etemadifar, M ^a   Saadatnia, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan MS Society   (Iran)

Author keywords

Epidemiology; Iran; Isfahan; Primary progressive multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBELLUM DISEASE; COGNITIVE DEFECT; DIPLOPIA; DISEASE COURSE; ETHNIC DIFFERENCE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IRAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; POLIOMYELITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; VERTIGO; VISUAL DISORDER;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLIOMYELITIS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 33947604073     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01680.x     Document Type: Article

References (40)

1. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-911.
2. Kremenchutzky M, Cottrell D, Rice G, et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 1999; 122: 1941-1950.
3. Filippi M, Campi A, Martinelli V, Pereira C, Scotti G, Comi G. Transitional progressive multiple sclerosis: MRI and MTI findings. Acta Neurologica Scandinavica 1995; 92: 178-182.
4. Weinshenker BG. Natural history of multiple sclerosis. Annals of Neurology 1994; 36(Suppl.): S6-S11.
5. Bonduelle M, Albaranes R. Statistical study of 145 cases of multiple sclerosis. La Semaine des hôpitaux de Paris 1962; 38: 3762-3773.
6. Minderhoud JM, van der Hoeven JH, Prange AJ. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurologica Scandinavica 1988; 78: 10-15.
7. Leibowitz U, Alter M, Halpern L. Clinical studies of multiple sclerosis in Israel. 3: clinical course and prognosis related to age at onset. Neurology 1964; 14: 926-932.
8. Bencsik K, Rajda C, Fuvesi J et al. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrad County, Hungary. European Neurology 2001; 46: 206-209.
9. Kalanie H, Gharagozli K, Kalanie AR. Multiple sclerosis: report on 200 cases from Iran. Multiple Sclerosis 2003; 9: 36-38.
10. Montalban X, Rio J. Primary progressive multiple sclerosis. Neurological Sciences 2001; 22(Suppl. 2): S41-S48.
11. Shepherd DI. Clinical features of multiple sclerosis in north-east Scotland. Acta Neurologica Scandinavica 1979; 60: 218-230.
12. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103: 281-300.
13. Thompson AJ, Polman CH, Miller DH et al. Primary progressive multiple sclerosis. Brain 1997; 120: 1085-1096.
14. Sumelahti ML, Tienari PJ, Hakama M, Wikstrom J. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses. Journal of Neurology, Neurosurgery, and Psychiatry 2003; 74: 25-28.
15. McDonnell GV, Hawkins SA. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. Journal of Neurology, Neurosurgery, and Psychiatry 1998; 64: 451-454.
16. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990; 300: 631-634.
17. Thompson AJ, Kermode AG, MacManus DG, et al. Pathogenesis of progressive multiple sclerosis. Lancet 1989; 1: 1322-1323.
18. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994; 117: 759-765.
19. de Sa' J, Magalhàes MA. Multimodal evoked potentials in primary progressive and relapsing/remitting MS forms. ECTRIMS 9th Congress Book of Abstracts 1993; 90.
20. Giovannoni G, Thorpe JW, Kidd D et al. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. Journal of Neurology, Neurosurgery, and Psychiatry 1996; 60: 20-26.
21. Olerup O, Hillert J, Fredrikson S et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 7113-7117.
22. Hillert J, Gronning M, Nyland H, Link H, Olerup O. An immunogenetic heterogeneity in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1992; 55: 887-890.
23. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. Journal of neurovirology 2000; 6(Suppl. 2): S134-S140.
24. Etemadifar M, Janghorbani M, Shaygannejad V, et al. Prevalence of Multiple Sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27: 39-44.
25. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001; 50: 121-127.
26. Thompson AJ, Montalban X, Barkhof F et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Annals of Neurology 2000; 47: 831-835.
27. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
28. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Multiple Sclerosis 1999; 5: 244-250.
29. Oken BS, Flegal K, Zajdel D, et al. Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity. Journal of rehabilitation research and development 2006; 43: 83-90.
30. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-166.
31. Andersson PB, Waubant E, Gee L, Goodkin DE. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Archives of neurology 1999; 56: 1138-1142.
32. McDonnell GV, Hawkins SA. Primary progressive multiple sclerosis (PPMS) in Northern Ireland [abstract]. Journal of neurology 1996; 243(Suppl. 2): S2-S5.
33. Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999; 122: 625-639.
34. Larsen JP, Kvaale G, Riise T, Nyland H, Aarli JA. Multiple sclerosis-more than one disease? Acta Neurologica Scandinavica 1985; 72: 145-150.
35. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.
36. Dujmovic I, Mesaros S, Pekmezovic T, Levic Z, Drulovic J. Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria. European Journal of Neurology: The Official Journal of The European Federation of Neurological Societies 2004; 11: 439-444.
37. Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MS in British Columbia, Canada. Neurology 2005; 65: 1919-1923.
38. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. Journal of the Neurological Sciences 1995; 132: 222-227.
39. Vleugels L, Pfennings L, Pouwer F, et al. Psychological functioning in primary progressive versus secondary progressive multiple sclerosis. The British Journal of Medical Psychology 1998; 71: 99-106.
40. Nielsen NM Wohlfahrt J, Melbye M, et al. Multiple sclerosis and poliomyelitis. A Danish historical cohort study. Acta Neurologica Scandinavica 2000; 101: 384-387.